Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

Inclusion Criteria:

1. Healthy, male and nonpregnant female subjects, 18 years of age or older.

2. A diagnosis of severe papulopustular rosacea using the Investigator Global Assessment
grading scale at baseline

3. Subjects with the presence of telangiectasia at Baseline

4. Subjects with the presence of facial erythema associated with their rosacea at
Baseline

Exclusion Criteria:

1. Subjects with steroid rosacea or subtype 3 (phymatous rosacea).

2. Subjects with nodular rosacea

3. Standard exclusion criteria.